Blackford and Brainomix partner to expand access to stroke care worldwide.
Blackford and Brainomix, two pioneering companies in the medical imaging and AI-powered solutions space, have announced a strategic partnership to bring Brainomix’s comprehensive e-Stroke solution to the Blackford Platform. The e-Stroke solution is designed to improve access to advanced stroke care for more institutions around the world. According to the World Stroke Organization, there are over 12.2 million new strokes each year, and in rural areas access to advanced imaging may be limited. Brainomix’s e-Stroke AI tools can generate real-time interpretation of more widely available non-contrast CT exams, expanding access to life-saving stroke treatments.
The e-Stroke platform provides physicians with fast, effective, and accurate analysis of images to expedite treatment decisions. The e-Stroke Mobile app allows physicians to quickly and securely access, review, and share patient images and data to optimize workflow and facilitate faster transfer and treatment decisions. Brainomix’s AI-powered e-Stroke tools have been used in more than 30 countries worldwide and have been shown to optimize networks and improve patient outcomes.
Blackford has worked in partnership with leading hospitals and technology providers for over a decade to integrate best-fit AI into clinical workflows to realize ongoing value. Partnering with Blackford provides healthcare organizations access to the widest available portfolio of AI solutions via a single tried-and-tested platform.
The strategic partnership between Blackford and Brainomix is a major step towards improving access to advanced stroke care for more institutions around the world. The e-Stroke solution provides physicians with fast and accurate analysis of images to expedite treatment decisions and the e-Stroke Mobile app facilitates faster transfer and treatment decisions. Brainomix’s AI-powered e-Stroke tools have been used in more than 30 countries worldwide and have been shown to optimize networks and improve patient outcomes. Blackford provides access to the widest available portfolio of AI solutions via a single tried-and-tested platform. This partnership will help to improve patient outcomes and expand access to critical endovascular therapy for stroke patients.
News Source